BlueRock Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- BlueRock Therapeutics's estimated annual revenue is currently $104.6M per year.
- BlueRock Therapeutics's estimated revenue per employee is $155,000
Employee Data
- BlueRock Therapeutics has 675 Employees.
- BlueRock Therapeutics grew their employee count by 33% last year.
BlueRock Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Assay Development | Reveal Email/Phone |
2 | Head Supply Chain and CMC Strategy | Reveal Email/Phone |
3 | Head CNS Biology | Reveal Email/Phone |
4 | SVP, Head Finance | Reveal Email/Phone |
5 | Sr. Director Strategy & Enterprise Operations | Reveal Email/Phone |
6 | Director FP&A | Reveal Email/Phone |
7 | Director FP&A | Reveal Email/Phone |
8 | Director Facilities and EHS | Reveal Email/Phone |
9 | Chief Technology Officer | Reveal Email/Phone |
10 | Associate Director, Information Technology | Reveal Email/Phone |
BlueRock Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is BlueRock Therapeutics?
BlueRock Therapeutics is a next-generation regenerative medicine company focused on breakthrough stem cell technology treatments of cardiovascular and neurodegenerative diseases. BlueRock Therapeutics has launched with the backing of a combined $225 million investment by Bayer and biotechnology investment firm Versant Ventures. BlueRock’s initial programs will focus on induced pluripotent stem cell (iPSC)-derived therapeutics to expand their technology pipeline.
keywords:N/A
N/A
Total Funding
675
Number of Employees
$104.6M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BlueRock Therapeutics News
In 2019, Bayer fully acquired BlueRock Therapeutics, a cell therapy developer it had formed three years earlier as a joint venture with...
Some of Leaps' bets so far have been in cell therapy, including BlueRock Therapeutics, which Bayer eventually fully acquired for up to $600 million in 2019.
... innovation for cell and gene therapies, says Bayer's Jens Vogel. ... when it bought out cell therapy developer BlueRock Therapeutics.
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $121.6M | 684 | -12% | $481M |
#2 | $101.1M | 708 | 27% | N/A |
#3 | $324.7M | 718 | 27% | N/A |
#4 | $53.7M | 721 | 6% | $484M |
#5 | $153.1M | 729 | 5% | N/A |